3D lung surgery planning with a dye to find tumors
Part of Cancer, Lungs & breathing clinical trials.
This trial tests a new way to plan and guide lung cancer surgery using a special dye that shows the tumor area during the operation. It may help surgeons remove the cancer more accurately while targeting only a small section of lung for certain early-stage patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your lung tumor is smaller than 3 cm
- You have early-stage non-small cell lung cancer (stage 1)
- Scans show the tumor is limited to one specific lung segment and you’re a candidate for segment removal
- You are not allergic to indocyanine green (ICG), sodium iodide, or iodine
- Your pregnancy/breastfeeding status and birth control fit the trial safety rules
- Your pre-surgery lung tests are strong enough (FEV1 and DLCO are above 30% of predicted)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new way to help surgeons remove lung cancer more precisely using virtual reality and a special dye. It might help ensure the cancer is fully removed while saving as much healthy lung as possible.
This early-stage trial tests a robotic lung surgery that uses a special dye with near-infrared light to help the surgeon remove only the tumor area. If you have a small, early lung cancer, this approach may help improve accuracy while limiting how much lung is removed.
This study tests whether 3D models made from non-contrast CT scans are accurate enough to guide minimally invasive lung segmentectomy (removing a small piece of the lung) for early-stage lung cancer. It may help certain patients avoid the need for contrast dye.
This trial tests a special imaging technique that uses a harmless dye to help surgeons see the exact boundary between healthy and diseased lung tissue during surgery to remove a small part of the lung. This could help make the surgery more precise and potentially preserve more healthy lung.
This trial tests a single dose of a special dye (LS301-IT) that helps surgeons see lung cancer cells more clearly during surgery. It aims to make lung cancer removal more precise and complete.
This trial tests a new way to guide lung surgery by using a 3D map of the lung's natural zones (watersheds) to find the best spot to remove a small lung nodule. It aims to help doctors remove just the right amount of lung tissue while preserving as much healthy lung as possible.
Hear when a new Non Small Cell Lung Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.